Tejas Patil, University of Colorado Cancer Center (IMAGE)

University of Colorado Anschutz Medical Campus

Tejas Patil, University of Colorado Cancer Center

Caption

Tejas Patil, MD, and colleagues say rare drug side effect highlights need for doctor vigilance when using new, targeted anti-cancer drugs.

Credit

University of Colorado Cancer Center

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.